The Current Research Status of Traditional Chinese Medicine Combined with Other Therapies in the Treatment of Primary Liver Cancer

原发性肝癌目前仍是全球的重要癌症之一，仍对人类健康有严重威胁，目前已经有许多研究证实中医药在对于肝癌的治疗中有着独特的优势。如今，中西医结合治疗原发性肝癌已经是大势所趋。通过探索相关中医证候和中医药对原发性肝癌中医药治疗联合其他治疗的临床研究，探讨分析当今中医药联合手术、消融、TACE、靶向、免疫治疗原发性肝癌的临床疗效和安全性，并对其进行综合性分析。最终发现在西医治疗的基础上联合中医药治疗能够在提高患者的临床疗效、延长患者生存率、减少肿瘤复发概率、缓解不良反应等方面都发挥了重要作用。Primary liver cancer is still one of the important cancers worldwide at present and still poses a serious threat to human health. At present, many studies have confirmed that traditional Chinese medicine has unique advantages in the treatment of liver cancer. Nowadays, the combination of traditional Chinese and Western medicine in the treatment of primary liver cancer has become a general trend. By exploring relevant traditional Chinese medicine syndromes and clinical studies on the combination of traditional Chinese medicine and other treatments in the treatment of primary liver cancer, exploring and analyzing the clinical efficacy and safety of traditional Chinese medicine combined with surgery, ablation, TACE, targeted and immunotherapy in the treatment of primary liver cancer at present, and conducting comprehensive analysis, eventually, it is found that on the basis of Western medicine treatment, the combination of traditional Chinese medicine treatment can play an important role in improving the clinical efficacy of patients, prolonging the survival rate of patients, reducing the probability of tumor recurrence, and alleviating adverse reactions.